# Kain Capital

Kain Capital is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** www.kaincap.com
- **LinkedIn:** https://www.linkedin.com/company/kain-capital-llc

## Regulatory record

- **CRD number:** 315669
- **SEC file number:** 801-123500
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/315669

## About

Kain Capital is an SEC-registered investment adviser in New York, NY, registered since 2022. The firm manages approximately $802 million in regulatory assets. It has 14 employees and 8 investment advisers.

## Sectors

- Enterprise Software
- Digital Health
- FinTech
- AI/ML

## People

- Kunal Kain — Founder & Managing Partner

## Questions

### What is Kain Capital's investment strategy?

Kain Capital pursues control-oriented growth and buyout investments in the lower middle market, focusing on technology-enabled business services and healthcare. The firm targets founder-led companies with $5 million to $25 million in revenue and applies an operating-intensive model — installing management systems, refining go-to-market approaches, and funding follow-on acquisitions. The strategy is concentrated and sector-specific rather than broadly opportunistic.

### How does Kain Capital source deals?

Kain sources primarily through domain-specialist intermediaries, sector conferences, and direct outreach to founder-owners in targeted verticals. The firm's operational reputation in healthcare IT and compliance software creates a referral channel from executives who have worked with Kain-backed companies. The firm does not run a broad auction-process strategy, preferring proprietary and limited-process situations where operational complexity suppresses competition.

### What sectors does Kain Capital explicitly avoid?

Kain does not invest in commodity-manufacturing, natural resources, or capital-intensive infrastructure. The firm's thesis confines it to asset-light, technology-enabled services and healthcare companies where operational intervention — not balance-sheet engineering — drives returns. Hard-tech, biotech, and consumer-facing retail are absent from the firm's disclosed portfolio activity.

## Related profiles

- [Kailai Capital](https://altss.com/profile/kailai-capital)
- [Kainjoo](https://altss.com/profile/kainjoo)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/kain-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology